Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,981 | -29,844 | -26,023 | -18,860 | -9,106 |
| Depreciation Amortization | 641 | 2,580 | 1,939 | 1,294 | 681 |
| Accounts receivable | -193 | 1,046 | 272 | 633 | 27 |
| Accounts payable and accrued liabilities | -424 | -574 | -1,001 | -924 | -672 |
| Other Working Capital | -493 | -771 | -1,140 | -639 | -731 |
| Other Operating Activity | 1,206 | 3,885 | 4,532 | 4,131 | 2,094 |
| Operating Cash Flow | $-6,244 | $-23,678 | $-21,421 | $-14,365 | $-7,707 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 637 | 14,445 | 14,693 | 14,490 | 12,424 |
| PPE Investments | -333 | -1,171 | -972 | -747 | -442 |
| Investing Cash Flow | $304 | $13,274 | $13,721 | $13,743 | $11,982 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | 10,000 | N/A | N/A |
| Common Stock Issued | 268 | 28 | 7 | 7 | 7 |
| Other Financing Activity | -215 | -685 | -308 | -476 | -107 |
| Financing Cash Flow | $53 | $9,343 | $9,699 | $-469 | $-100 |
| Exchange Rate Effect | -93 | -2,284 | -2,464 | -2,367 | -487 |
| Beginning Cash Position | 28,980 | 32,325 | 32,325 | 32,325 | 32,325 |
| End Cash Position | 23,000 | 28,980 | 31,860 | 28,867 | 36,013 |
| Net Cash Flow | $-5,980 | $-3,345 | $-465 | $-3,458 | $3,688 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,244 | -23,678 | -21,421 | -14,365 | -7,707 |
| Capital Expenditure | -359 | -1,171 | -972 | -747 | -442 |
| Free Cash Flow | -6,603 | -24,849 | -22,393 | -15,112 | -8,149 |